Aura Panel Discussion August 2020
In August 2020, GENETWORx’s expert panelists gathered again to discuss the COVID-19 crisis and how GENETWORx’s new data management software Aura is helping businesses, healthcare facilities, schools, and more keep their populations safe while keeping their doors open.
In this panel discussion, you’ll learn:
- What does Aura have to offer? Who would benefit the most from it?
- How quickly can GENETWORx expedite test results? What is GENETWORx’s testing capacity?
- How can businesses, universities, etc. prepare for a surge in cases?
- What else do businesses, universities, etc. need besides testing to keep their populations safe?
- A step-by-step demonstration of Aura and all of its features
The panelists included Steven Paolucci, CTO/Architect at GENETWORx and Matt Etheridge, VP of Sales and Marketing at GENETWORx.
“We’ve listened to the pain points, the needs of you and your patients, to figure out what we can do better. Standing still in this space is not an option. [Aura] is the next evolution of taking yet another step to develop outstanding service to our customers and the patients they provide service for. Bottom line is, testing is one thing. Question is, what else do you really need? Aura serves as a data management system, a scheduling platform, an all-encompassing program to give you exactly what they’ve been asking for,” says Matt.
Please see a free recording of the event below. If you’d like to learn more about Aura or GENETWORx’s diagnostic and antibody testing, contact our COVID-19 suppression team.
COVID-19 Panel Discussion July 2020
In July 2020, GENETWORx organized a team of expert panelists to discuss the top questions community leaders face amidst the threat of COVID-19:
- How can organizations and schools ensure that frontline workers, faculty, students, or healthcare professionals are able to work and study safely?
- What is needed to put a comprehensive testing and monitoring plan in place for COVID-19 suppression?
- What are the differences between COVID-19 and Antibody testing? Does it matter which test you get?
- What is sequential population management?
- How does partnering with GENETWORx help make a COVID-19 suppression plan successful?
The panelists included John Hopkins, DO, President and Founder of CSS Healthcare, Steven Paolucci, CTO/Architect at GENETWORx, Sarah Jacobs-Helber, PhD, HCLD (ABB), Chief Laboratory Officer at GENETWORx, and Matt Etheridge, VP of Sales and Marketing at GENETWORx.
A free recording of this event is posted here. We encourage everyone to view and share this vital information as our country aims to find its “new normal.” Contact our COVID-19 suppression team to speak with laboratory experts about a plan for your organization.
John Hopkins, DO
President and Founder, CCS Healthcare
Dr. Hopkins began his medical career in his home town of Philadelphia, PA. After residency, he practiced in various landscapes throughout the United States to better understand the variance of health care disparities that exist driven by socioeconomic status. Additionally he spent time overseas evaluating the pragmatic application of a public healthcare system. His efforts are now focused on the CCS delivery system driven by a desire to continuously improve the process for the benefit of our patients. CCS Healthcare is currently doing 1,000 COVID-19 tests / day through GENETWORx.
Steven Paolucci – CTO/Architect
Chief architect and team lead on the Aura sequential testing and certification platform for COVID-19 and other infectious diseases, Steve has spent the last few years developing AI/tech-driven recruiting platforms enabling SMART, seamless recruiting, onboarding and placement, optimize worker performance, and warehouse process optimization.
Some of Steve’s projects include developing an employee performance appraisal system for OMB at the White House, the PDX platform for Laborocity, and the matching algorithm based Bullseye Applicant Tracking System. Steve has also worked on enterprise banking fintech solutions, using the Blockchain to track assets for Proof of Ownership.
Steve holds a Bachelor’s of Science in Electrical and Electronics Engineering from Boston University (Dean’s List).
Sarah Jacobs-Helber, PhD, HCLD (ABB)
Chief Laboratory Officer
Sarah Jacobs-Helber, PhD, HCLD (ABB) has more than 20 years of experience in laboratory management and molecular testing and brings considerable expertise to GENETWORx’s Laboratory. Dr. Jacobs-Helber joined GENETWORx in 2013 as the Laboratory Director of the high-complexity clinical laboratory and now serves as the Chief Laboratory Officer. Prior to her position at GENETWORx, she served as the Clinical Director of American International Biotechnology (AIBiotech) in Richmond, VA. Dr. Jacobs-Helber received her Bachelor of Science degree in Biology from Bucknell University in Lewisburg, PA and her PhD in Microbiology/Immunology from the Medical College of Virginia in Richmond VA. Her post-doctoral research included time at the National Cancer Institute and the Department of Pharmacology/Toxicology at the Medical College of Virginia. She holds board certification as a high-complexity lab director from the American Board of Bioanalysis and also holds a Certificate of Qualification as the Director for Molecular Genetics and Parentage testing from the New York State Department of Health. She is the first author on numerous scientific articles published in high-impact journals.
Vice President of Sales and Marketing EAST
Matt Etheridge has more than 18 years of experience in medical sales, including pharmaceutical, medical device, biologic and laboratory spaces. He has a proven track record of success as an award winner in multiple organizations, both in sales and sales leadership and has spent 10 years in sales management, including 6 years in executive level leadership. Matt joined GENETWORx in January 2020 to lead their expansion into COVID-19 testing. Matt has extensive leadership and sales experience in large, medium and start up type organizations, is a graduate of the Georgia Institute of Technology, and a 3 time letter winner in Football.